Publications by authors named "Keith Stewart"

Claim this Profile
P
Prognostic Value of [18F]FDG PET/CT in Multiple Myeloma Patients at the Time of Initial Diagnosis.
Seyed Ali Mirshahvalad, Ahmed Alghamdi, Mohammadreza Chavoshi, Cornel Felder, Ur Metser, A Keith Stewart

Clin Nucl Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIKfyve inhibition in myeloma disrupts autophagy and the lysosome, increasing MHC expression and cholesterol metabolism.
Cecilia Bonolo De Campos, Ruijuan He, Tessa Josephine Pelino, Dor David Abelman, Zhihua Li, A Keith Stewart

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, Jill Corre, Mattia D'Agostino, A Keith Stewart

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, Jill Corre, Mattia D'Agostino, A Keith Stewart

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single-Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities.
Ashish Patel, Esther Masih-Khan, Adam Smith, Katherine Lajkosz, Sita Bhella, A Keith Stewart

EJHaem· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinsonism and Bilateral Facial Palsy after Chimeric Antigen Receptor T-Cell Therapy.
Annie Siyu Wu, Lauren Hophing, Paula Gosse, Mehras Motamed, Sita Devi Bhella, Keith Stewart

Mov Disord Clin Pract· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenic germ line variants in a prospective multicenter cohort of patients with multiple myeloma.
Julia Erin Wiedmeier-Nutor, Michael A Golafshar, Katie L Kunze, Edward D Esplin, Robert L Nussbaum, A Keith Stewart

Blood Neoplasia· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional variant rs9344 at 11q13.3 regulates CCND1 expression in multiple myeloma with t(11;14).
Hongwei Tang, Huihuang Yan, Suganti Shivaram, Stacey Lehman, Neeraj Sharma, A Keith Stewart

Leukemia· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mayo Clinic Tapestry Study: A Large-Scale Decentralized Whole Exome Sequencing Study for Clinical Practice, Research Discovery, and Genomic Education.
Lorelei A Bandel, Robert A Vierkant, Teresa M Kruisselbrink, Michelle L Bublitz, Tammy A Wilson, A Keith Stewart

Mayo Clin Proc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Belantamab Mafodotin Revival in Multiple Myeloma Therapy.
Suzanne Trudel, A Keith Stewart

N Engl J Med· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuous Elotuzumab, Pomalidomide, and Dexamethasone Maintenance Following Second Autologous Transplantation for Multiple Myeloma: Results of a Prospective Phase 2 Multicenter Trial.
Michael Slade, Mark A Fiala, Marie Kirchmeyer, Jeff King, Feng Gao, A Keith Stewart

Transplant Cell Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Landmark Paper That Introduced Proteasome Inhibition in Myeloma.
Anup Joseph Devasia, Guido Lancman, A Keith Stewart

Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjusted comparison of outcomes between patients from CARTITUDE-1 multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice.
Maria-Victoria Mateos, Katja Weisel, Thomas Martin, Jesús G Berdeja, Andrzej Jakubowiak, A Keith Stewart

Haematologica· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal Hematopoiesis of Indeterminate Potential Is Associated With Coronary Microvascular Dysfunction In Early Nonobstructive Coronary Artery Disease.
Nadia Akhiyat, Terra Lasho, Morsaleh Ganji, Takumi Toya, Chang-Xin Shi, Keith Stewart

Arterioscler Thromb Vasc Biol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mass Cytometry reveals unique phenotypic patterns associated with subclonal diversity and outcomes in multiple myeloma.
Linda B Baughn, Erik Jessen, Neeraj Sharma, Hongwei Tang, James B Smadbeck, A Keith Stewart

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, A Keith Stewart

Blood Cancer J· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma.
Radhika Bansal, Mizba Baksh, Jeremy T Larsen, Matthew A Hathcock, David Dingli, A Keith Stewart

Blood Cancer J· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients.
Rodrigo Fonseca, Mariano Arribas, Julia E Wiedmeier-Nutor, Yael N Kusne, Miguel González Vélez, A Keith Stewart

Blood Cancer J· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ciltacabtagene Autoleucel, an Anti-B-cell Maturation Antigen Chimeric Antigen Receptor T-Cell Therapy, for Relapsed/Refractory Multiple Myeloma: CARTITUDE-1 2-Year Follow-Up.
Thomas Martin, Saad Z Usmani, Jesus G Berdeja, Mounzer Agha, Adam D Cohen, A Keith Stewart

J Clin Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of integrated translational research on clinical exome sequencing.
Eric W Klee, Margot A Cousin, Filippo Pinto E Vairo, Joel A Morales-Rosado, Erica L Macke, A Keith Stewart

Genet Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label study.
Thomas Martin, Yi Lin, Mounzer Agha, Adam D Cohen, Myo Htut, A Keith Stewart

Lancet Haematol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional profiles define drug refractory disease in myeloma.
Yuan Xiao Zhu, Laura A Bruins, Xianfeng Chen, Chang-Xin Shi, Cecilia Bonolo De Campos, A Keith Stewart

EJHaem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma.
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesus F San-Miguel, Hermann Einsele, A Keith Stewart

Blood Cancer Discov· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of clonal hematopoiesis of indeterminate potential (CHIP) is not associated with race in patients with plasma cell neoplasms.
Marie-France Gagnon, Shulan Tian, Susan Geyer, Neeraj Sharma, Celine M Vachon, A Keith Stewart

Blood Cancer J· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coherent light filter.
Morgan Bergthold, Keith Stewart, Nicholas Duggar, Aaron J Muhowski, Daniel Wasserman

Opt Lett· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis